Patent · US Active

Compositions and methods of tolerizing a primate to an antigen

US7947272B2 · kind B2 · utility

0Cited by
3References
21Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJul 13, 2006
Grant dateMay 24, 2011
Priority date
Expiry dateMay 1, 2029

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/71
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Inducing tolerance in a primate by use of a compound, or a combination of at least two compounds, that has certain characteristics when tested in vitro. The compound, alone or in combination, is preferably TRX1 antibody and the compound or combination is preferably used in accordance with a specified dosing regimen.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.